Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti(Harvard University), Mark M. Awad(Memorial Sloan Kettering Cancer Center), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Andrew Polio(Harvard University), Xinan Wang(Harvard University), Giulia C. Leonardi(Harvard University), Bijaya Sharma(Brigham and Women's Hospital), Kristen D. Felt(Brigham and Women's Hospital), Matthew D. Hellmann(AstraZeneca (United States)), Andrew D. Cherniack(Broad Institute), Xihong Lin(Harvard University), Yvonne Y. Li(Broad Institute), Victor R. Vaz(Dana-Farber Cancer Institute), Andrew J. Plodkowski(Memorial Sloan Kettering Cancer Center), Rileen Sinha(Broad Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Kurt A. Schalper(Yale University), Pasi A. Jänne(Harvard University), Valsamo Anagnostou(Johns Hopkins University), Arvind Ravi(Broad Institute), Scott J. Rodig(Brigham and Women's Hospital), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), James Lindsay, Marissa Lawrence(Harvard University), Gonzalo Recondo(Dana-Farber Cancer Institute), Mizuki Nishino(Brigham and Women's Hospital), Hersh Gupta(Dana-Farber Cancer Institute), Brian S. Henick(NewYork–Presbyterian Hospital), Giuseppe Lamberti(Dana-Farber Cancer Institute), Justin F. Gainor(Harvard University), Joao V. Alessi(Hospital Sírio-Libanês), Navin R. Mahadevan(Brigham and Women's Hospital), Natalie I. Vokes(The University of Texas MD Anderson Cancer Center), Lynette M. Sholl(Brigham and Women's Hospital), David C. Christiani(Harvard University), Michael Tolstorukov(Dana-Farber Cancer Institute), Renato Umeton(Harvard University), Gad Getz(Broad Institute)
Cited by 383
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k